Zobrazeno 1 - 10
of 356
pro vyhledávání: '"Sarah P Psutka"'
Autor:
Wenzel M; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany. Electronic address: mike.wenzel@kgu.de., Chun FK; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany., Becker A; Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt am Main, Frankfurt, Germany.
Publikováno v:
European urology [Eur Urol] 2022 Nov; Vol. 82 (5), pp. e146-e147. Date of Electronic Publication: 2022 Aug 06.
Autor:
Montorsi F; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy., Capitanio U; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: capitanio.umberto@hsr.it., Rosiello G; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy., Larcher A; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy.
Publikováno v:
European urology [Eur Urol] 2022 Jun; Vol. 81 (6), pp. e149. Date of Electronic Publication: 2022 Mar 10.
Publikováno v:
European Urology. 82:e146-e147
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eb38b62dd8d58df8cbe4925af61251fe
https://doi.org/10.1016/j.eururo.2022.06.026
https://doi.org/10.1016/j.eururo.2022.06.026
Publikováno v:
European Urology. 81:e149
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ce851e43718eeaff21f30ba03b9eac4
https://doi.org/10.1016/j.eururo.2022.02.026
https://doi.org/10.1016/j.eururo.2022.02.026
Publikováno v:
Société Internationale d’Urologie Journal, Vol 3, Iss 6, Pp 437-449 (2022)
Surgery with either partial or radical nephrectomy remains the standard of care for localized primary renal cell carcinoma (RCC). However, most RCCs are detected in an older age group, and some may have multiple comorbidities that preclude surgery. T
Externí odkaz:
https://doaj.org/article/6a3e8201481e4091a48f6c0f7748928e
Publikováno v:
Société Internationale d’Urologie Journal, Vol 3, Iss 6, Pp 451-463 (2022)
Renal cell carcinoma (RCC) has a natural tendency to invade the venous system with formation of a venous tumor thrombus in the renal vein, which can extend proximally into the inferior vena cava (IVC) and in some cases into the right atrium. The pres
Externí odkaz:
https://doaj.org/article/2e6a46b89e4147c0a1fc6fdb048aa947
Autor:
Christopher Kwok, Adam Khorasanchi, Sarah P. Psutka, Megan Hinkley, Shawn Dason, Debasish Sundi, Yuanquan Yang, Yajing Yang, Claire Verschraegen, Evan E. Gross, Delaney Orcutt, Ming Yin
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe optimal treatment for metastatic renal cell carcinoma (mRCC) patients who have progressed after both immune checkpoint inhibitor (ICI) and VEGFR tyrosine kinase inhibitor (TKI) remains uncertain. Lenvatinib and everolimus (LE) are frequ
Externí odkaz:
https://doaj.org/article/1a1bbaa7531d4e81bd684d96082c63d7
Autor:
Yuanquan Yang, Sarah P. Psutka, Anish B. Parikh, Mingjia Li, Katharine Collier, Abdul Miah, Sherry V. Mori, Megan Hinkley, Scott S. Tykodi, Evan Hall, John A. Thompson, Ming Yin
Publikováno v:
Cancer Medicine, Vol 11, Iss 16, Pp 3106-3114 (2022)
Abstract Background Immune checkpoint inhibitor/tyrosine kinase inhibitor (ICI/TKI) combinations are a new standard of care for the initial treatment of metastatic renal cell carcinoma (mRCC). Their efficacy and toxicity beyond the first‐line setti
Externí odkaz:
https://doaj.org/article/5a0bc07a3300429c841ed05a5967d215
Autor:
Alexandra Medline, Eric Midenberg, Dattatraya Patil, Sean Evans, Nikhil Vettikattu, Fatima Kamal, Kenneth Ogan, Sarah P. Psutka, Mehmet Asim Bilen, Viraj A. Master
Publikováno v:
JCSM Rapid Communications, Vol 5, Iss 2, Pp 205-211 (2022)
Abstract Background Preoperative skeletal muscle deficiency is an established risk factor for poor survival outcomes in patients with renal cell carcinoma (RCC). However, given the dynamic nature of skeletal muscle associated with malignancy, there i
Externí odkaz:
https://doaj.org/article/5801308526a844d2b837cb3880bb9e49
Autor:
Sarah P. Psutka, Susan Veleber, Jonathan Siman, Samia Jannat, Sarah Holt, Jonathan L. Wright, Heather Greenlee
Publikováno v:
Contemporary Clinical Trials Communications, Vol 30, Iss , Pp 101044- (2022)
Background: Treatment-related serious adverse events (SAEs) are common in patients receiving intravesical Bacillus Calmette-Guerin (BCG) for the treatment of high-risk nonmuscle-invasive bladder cancer (NMIBC). Here we describe the protocol of a rand
Externí odkaz:
https://doaj.org/article/d7386dc3beaf4473bf01166b078f84f3